Literature DB >> 29217473

Impact of digestion on the transport of dextran-loaded self-emulsified nanoemulsion through MDCK epithelial cell monolayer and rat intestines.

Pulkit Khatri1, Jun Shao2.   

Abstract

Many of the lipids and surfactants used to prepare the self-emulsified nanoemulsion (SEN) are subjected to the gastro-intestinal enzymatic digestion, which may affect the absorption of the loaded drug. The present study was to investigate the impact of such digestion on the transport of hydrophilic macromolecules (10-kDa dextran as the model compound) loaded in SEN through the MDCK cell monolayer and ex-vivo rat intestines. FITC-labeled dextran (FD) was loaded inside the inner oil phase of SEN by the formation of FD-phospholipid solid dispersion (FDPS). After digestion, the droplet size increased from 31.06 ± 2.10 nm to 494.6 ± 22.1 nm, and the FD content in the external aqueous phase increased from 41.6 ± 4.2% to 61.1 ± 4.4%. Compared to the FD solution, SEN without digestion enhanced the transport of FD through MDCK cell monolayer 4.1 times and through rat intestines 3.0-7.4 times. However, the digestion reduced the transport of FD 3.5 times through MDCK cell monolayer and 1.3-2.0 times through rat intestines, compared to that without digestion. This reduction was due to the destruction of lipid nano-droplets and release of FD to the external aqueous phase of SEN. This finding should be considered when SEN is used as a delivery system for hydrophilic macromolecules.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Digestion; Ex-vivo rat intestine; MDCK cell monolayer; Macromolecule; Nanoemulsion; Oral delivery; Transport

Mesh:

Substances:

Year:  2017        PMID: 29217473     DOI: 10.1016/j.ijpharm.2017.12.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System.

Authors:  Chen Jianxian; Kalsoom Saleem; Muhammad Ijaz; Masood Ur-Rehman; Ghulam Murtaza; Mulazim Hussain Asim
Journal:  Int J Nanomedicine       Date:  2020-07-23

2.  Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification.

Authors:  Hongliang Wang; Lin Li; Jun Ye; Wujun Dong; Xing Zhang; You Xu; Jinping Hu; Rubing Wang; Xuejun Xia; Yanfang Yang; Dujia Jin; Renyun Wang; Zhihui Song; Lili Gao; Yuling Liu
Journal:  Molecules       Date:  2021-01-18       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.